Xact Kapitalforvaltning’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Xact Kapitalforvaltning’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-6,000	Closed	-$676K	–	1324
2017 Q3	$676K	Hold	6,000	–	–	0.02%	566
2017 Q2	$672K	Hold	6,000	–	–	0.02%	571
2017 Q1	$700K	Buy	6,000 +500	+9%	+$55.3K	0.02%	568
2016 Q4	$579K	Sell	5,500 -800	-13%	-$83.8K	0.02%	584
2016 Q3	$696K	Buy	+6,300	New	+$834K	0.02%	537

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Xact Kapitalforvaltning's TARO Position: Q4 2017 in Review

Xact Kapitalforvaltning sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2017, closing a stake of 6,000 shares — an estimated $676K sold.

Xact Kapitalforvaltning first reported a position in TARO in Q3 2016 and held it in 5 quarters. The position peaked at $700K in Q1 2017. 127 funds tracked by Wall St. Rank hold TARO as of Q4 2017.

Xact Kapitalforvaltning reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2017 after selling out during the quarter.
Xact Kapitalforvaltning sold 6,000 Taro Pharmaceutical Industries Ltd. shares in Q4 2017, an estimated $676K.
Xact Kapitalforvaltning first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2016 and held it in 5 quarters.
Xact Kapitalforvaltning's Taro Pharmaceutical Industries Ltd. position peaked at $700K in Q1 2017.
127 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2017.

Based on Xact Kapitalforvaltning's 13F filing for Q4 2017, filed 8 Feb 2018.